http://blog.wenxuecity.com/myblog/66653/201505/6913.html
今天来自IMS Health的报告说,癌症要不但是美国花费最高的,也是世界上花费最大的,过千亿美元,同比过10%。IMS Health预测今后几年年增长率约6-8%。
这是IMS Health提供的图表:
美欧5【注1】日是大头,三地区占了四分之三。估计中国没多少,太贵了,贪官还凑乎。
不管如何,钱都是欧美大制药公司赚了,Bristol-Myers Squibb, Merck, Roche, AstraZeneca。
世界卫生组织的报告:Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012 (1). The most common causes of cancer death are cancers of:
- lung (1.59 million deaths)
- liver (745 000 deaths)
- stomach (723 000 deaths)
- colorectal (694 000 deaths)
- breast (521 000 deaths)
- oesophageal cancer (400 000 deaths) (1).
穷国家,落后,啥都落后,出口多少小虾小鱼才够啊。
这是癌症现状(下)提到的相关资料:
2015.04.03
Why Are Cancer Drugs So Expensive in the U.S.?
2015.03.16
Oncologists reveal reasons for high cost of cancer drugs in U.S.
2015.03.28
5 Freakishly Expensive Cancer Drugs
这是癌症现状(下)提到的相关资料:
2015.04.03
Why Are Cancer Drugs So Expensive in the U.S.?
2015.03.16
Oncologists reveal reasons for high cost of cancer drugs in U.S.
2015.03.28
5 Freakishly Expensive Cancer Drugs
No. 5: Xofigo, $12,657 monthly cost per patient(晚期前列腺癌)
No. 4: Cyramza, $13,256 monthly cost per patient(非小细胞肺癌、胃癌)
No. 3: Zykadia, $13,672 monthly cost per patient(ALK-positive NSCLC型肺癌)
No. 2: Lenvima, $13,945 monthly cost per patient(甲状腺癌)
No. 1: Blincyto, $64,260 monthly cost per patient(急性淋巴性白血病)
参见:
癌症现状(上)
癌症现状(下)
【注1】欧5:欧洲5大药国,德法英西意。
【注2】路透社:Global cancer drug spending hits $100 billion in 2014: IMS Health
【注3】IMS Health公布